Online Adaptive MR-Guided Ultrahypofractionated Radiotherapy of Prostate Cancer on a 1.5 T MR-Linac: Clinical Experience and Prospective Evaluation

The use of hypofractionated radiotherapy in prostate cancer has been increasingly evaluated, whereas accumulated evidence demonstrates comparable oncologic outcomes and toxicity rates compared to normofractionated radiotherapy. In this prospective study, we evaluate all patients with intermediate-ri...

Full description

Bibliographic Details

Published in:	Current Oncology
Main Authors:	Vlatko Potkrajcic, Cihan Gani, Stefan Georg Fischer, Simon Boeke, Maximilian Niyazi, Daniela Thorwarth, Otilia Voigt, Moritz Schneider, David Mönnich, Sarah Kübler, Jessica Boldt, Elgin Hoffmann, Frank Paulsen, Arndt-Christian Mueller, Daniel Wegener
Format:	Article
Language:	English
Published:	MDPI AG 2024-05-01
Subjects:	prostate cancer hypofractionated radiotherapy MR-Linac
Online Access:	https://www.mdpi.com/1718-7729/31/5/203